Status | Study |
RECRUITING |
Study Name: A Retrospective Analysis of Outcomes in Patients With Hepatorenal Syndrome at Methodist Dallas Medical Center Condition: Hepatorenal Syndrome Date: 2023-07-06 Interventions: 1.2.1.To perform a retrospective analysis of patients with HRS with the aim of comparing various treatment modalities such as vasoconstrictors, |
RECRUITING |
Study Name: Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome Condition: Hepatorenal Syndrome Date: 2023-05-01 Interventions: Pharmaceutical form: sterile 2R vials containing 10 mg of R2R01. |
Recruiting |
Study Name: A Study To Confirm Efficacy and Safety of Terlipressin in HRS Type 1 Condition: Hepatorenal Syndrome Date: 2016-05-10 Interventions: Drug: Terlipressin acetate Lyo |
Completed |
Study Name: To Compare the Response Rate of Noradrenaline vs. Terlipressin in Hepatorenal Syndrome in Patients With Acute on Chronic Liver Failure Condition: Acute on Chronic Liver Failure Date: 2015-10-05 Interventions: Drug: Nor adrenaline + albumin Drug: Terli |
Recruiting |
Study Name: The Effect of Terlipressin in the Prevention of Type 2 Hepatorenal Syndrome by Improving Mean Arterial Pressure Condition: Hepatorenal Syndrome Date: 2015-07-01 Interventions: Drug: Terlipressin |
Recruiting |
Study Name: Use of Novel Plasma and Urinary Biomarkers to Predict the Development of Hepatorenal Syndrome in Cirrhotic Patients Condition: Hepatorenal Syndrome Date: 2015-04-30 |
Recruiting |
Study Name: Outcomes of Renal Function in Hepatorenal Syndrome (HRS) Determined By Comparison of Target Mean Arterial Pressure (MAP) of 65 - 70 Mmhg Versus ≥ 85 Mmhg Condition: Hepatorenal Syndrome Date: 2015-01-28 Interventions: Drug: Norepinephrine (Levophed) |
Terminated |
Study Name: Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline Condition: Hepatorenal Syndrome Date: 2014-04-18 Interventions: Drug: Pentoxyfylline Drug: Placebo |
Recruiting |
Study Name: Study of Accuracy of NGAL, a Renal Injury Biomarker, in Patients With Cirrhosis Condition: Acute Kidney Injury Hepatorenal Syndrome Date: 2014-01-27 |
Completed |
Study Name: Treatment of Type-1 Hepatorenal Syndrome Associated With Sepsis Condition: Hepatorenal Syndrome Date: 2013-08-14 Interventions: Drug: Terlipressin and albumin Single-group study (Type-1 |